Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for PRAX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 758.55M
March 31, 2026 786.86M
December 31, 2025 599.33M
September 30, 2025 267.16M
June 30, 2025 301.28M
March 31, 2025 327.99M
December 31, 2024 392.57M
September 30, 2024 357.03M
June 30, 2024 351.88M
March 31, 2024 207.42M
December 31, 2023 81.30M
September 30, 2023 101.08M
June 30, 2023 124.30M
March 31, 2023 85.82M
Date Value
December 31, 2022 100.49M
September 30, 2022 123.74M
June 30, 2022 165.40M
March 31, 2022 222.52M
December 31, 2021 275.91M
September 30, 2021 314.97M
June 30, 2021 340.20M
March 31, 2021 271.41M
December 31, 2020 297.21M
September 30, 2020 114.77M
June 30, 2020
March 31, 2020
December 31, 2019 44.82M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Heron Therapeutics, Inc. 42.66M
Insmed, Inc. 1.160B
Ionis Pharmaceuticals, Inc. 2.055B
Perspective Therapeutics, Inc. 236.88M
Regeneron Pharmaceuticals, Inc. 8.005B